Live feed
Filing
SC 13G/A
SC 13G/A0000921895-24-002971·BIOTECHNOLOGY VALUE FUND L P
Schedule 13G ownership disclosure
Palvella Therapeutics Inc
Security class unavailable · CUSIP: 697947109
Event date: 2024-12-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-24-002971
- Form type
- SC 13G/A
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Dec 17, 2024
- Reporting period
- Dec 13, 2024
- Description
- Schedule 13G beneficial ownership